ClinicalTrials.gov
ClinicalTrials.gov Menu

Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00293527
Recruitment Status : Withdrawn (Withdrawn in October 2006, no longer of interest)
First Posted : February 17, 2006
Last Update Posted : May 23, 2013
Sponsor:
Information provided by (Responsible Party):
Thomas Olencki, Ohio State University Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : November 2006